Clinical Study to Assess the Efficacy and Safety of DF277 Compared to Placebo in the Treatment of Otic Eczema

Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis

NCT06144424 ·Status: COMPLETED ·Phase: PHASE2

Oral DS107 in Moderate to Severe Atopic Dermatitis

NCT02211417 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids

NCT03861455 ·Status: COMPLETED ·Phase: PHASE2

A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis

NCT02424253 ·Status: COMPLETED ·Phase: PHASE2

A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis

NCT02795832 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

NCT02277743 ·Status: COMPLETED ·Phase: PHASE3

Study of OPA-15406 Ointment in Patients With Atopic Dermatitis

NCT02914548 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Study of KHK4577

NCT02004119 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis.

NCT06756438 ·Status: RECRUITING ·Phase: NA

This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)

NCT05608343 ·Status: COMPLETED ·Phase: PHASE3

Non Interventional Clinical Investigation of Ectoin Ear Spray in Skin Treatment of Outer Ear Canal Irritations

NCT02558738 ·Status: COMPLETED

Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis

NCT04668066 ·Status: COMPLETED ·Phase: PHASE1

Effect of OC000459 on Moderate to Severe Atopic Dermatitis

NCT02002208 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients

NCT02864498 ·Status: COMPLETED ·Phase: PHASE2

A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis

NCT00703573 ·Status: COMPLETED ·Phase: PHASE2

Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

NCT03627767 ·Status: COMPLETED ·Phase: PHASE3

A Study To Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy Participants

NCT04135560 ·Status: COMPLETED ·Phase: PHASE1

Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis

NCT06487000 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060

NCT01522391 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis

NCT01808157 ·Status: COMPLETED ·Phase: PHASE2

Induced Pluripotent Stem Cell Derived Exosomes for the Treatment of Atopic Dermatitis

NCT05969717 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis

NCT03091426 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

NCT07037901 ·Status: RECRUITING ·Phase: PHASE2

A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis

NCT03517566 ·Status: TERMINATED ·Phase: PHASE2

JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis

NCT03796676 ·Status: COMPLETED ·Phase: PHASE3